Steward Partners Investment Advisory’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-350
Closed -$7.91K 4371
2025
Q3
$7.91K Sell
350
-300
-46% -$6.18K ﹤0.01% 3501
2025
Q2
$12.9K Hold
650
﹤0.01% 3097
2025
Q1
$11K Hold
650
﹤0.01% 3047
2024
Q4
$12K Sell
650
-500
-43% -$9.76K ﹤0.01% 3022
2024
Q3
$25K Hold
1,150
﹤0.01% 2563
2024
Q2
$22.6K Hold
1,150
﹤0.01% 2474
2024
Q1
$25K Hold
1,150
﹤0.01% 2427
2023
Q4
$33.2K Sell
1,150
-29
-2% -$776 ﹤0.01% 2145
2023
Q3
$31.5K Hold
1,179
﹤0.01% 2115
2023
Q2
$43.7K Hold
1,179
﹤0.01% 1938
2023
Q1
$36.8K Hold
1,179
﹤0.01% 1985
2022
Q4
$35.1K Hold
1,179
﹤0.01% 1975
2022
Q3
$45K Hold
1,179
﹤0.01% 1836
2022
Q2
$64K Hold
1,179
﹤0.01% 1681
2022
Q1
$74K Sell
1,179
-600
-34% -$39.5K ﹤0.01% 1723
2021
Q4
$179K Hold
1,779
﹤0.01% 1356
2021
Q3
$160K Buy
1,779
+29
+2% +$2.64K ﹤0.01% 1358
2021
Q2
$161K Sell
1,750
-330
-16% -$26.3K ﹤0.01% 1708
2021
Q1
$201K Sell
2,080
-1,300
-38% -$134K ﹤0.01% 1299
2020
Q4
$176K Buy
3,380
+1,930
+133% +$80.6K ﹤0.01% 1126
2020
Q3
$58K Buy
+1,450
New +$45.4K ﹤0.01% 1437

Other funds holding FLGT

Steward Partners Investment Advisory's FLGT Position: Q4 2025 in Review

Steward Partners Investment Advisory sold out of Fulgent Genetics (FLGT) in Q4 2025, closing a stake of 350 shares — an estimated $7.91K sold.

Steward Partners Investment Advisory first reported a position in FLGT in Q3 2020 and held it in 21 quarters. The position peaked at $201K in Q1 2021. 179 funds tracked by Wall St. Rank hold FLGT as of Q4 2025.

  • Steward Partners Investment Advisory reported no remaining Fulgent Genetics position as of Q4 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 350 Fulgent Genetics shares in Q4 2025, an estimated $7.91K.
  • Steward Partners Investment Advisory first reported a position in Fulgent Genetics in Q3 2020 and held it in 21 quarters.
  • Steward Partners Investment Advisory's Fulgent Genetics position peaked at $201K in Q1 2021.
  • 179 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2025, filed 12 Feb 2026.